Cleared Traditional

K863240 - PROLACTIN RIABEAD II DIAGNOSTIC KIT

K863240 is an FDA 510(k) clearance for PROLACTIN RIABEAD II DIAGNOSTIC KIT, manufactured by Abbott Laboratories. The device is a Class 1 Chemistry device with product code CFT cleared through the Traditional 510(k) pathway after a 38-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1986
Decision
38d
Days
Class 1
Risk

K863240 is an FDA 510(k) clearance for the PROLACTIN RIABEAD II DIAGNOSTIC KIT. Classified as Radioimmunoassay, Prolactin (lactogen) (product code CFT), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on September 29, 1986 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1625 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K863240

510(k) Number K863240 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 1986
Decision Date September 29, 1986
Days to Decision 38 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 88d · This submission: 38d
Pathway characteristics
Predicate-based equivalence.

CFT Device Classification - Class 1, General Controls

Product Code CFT Radioimmunoassay, Prolactin (lactogen)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1625
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CFT Radioimmunoassay, Prolactin (lactogen)

All 56
Devices cleared under the same product code (CFT) and FDA review panel - the closest regulatory comparables to K863240.
PRL SEROZYME IMMUNOENZ. ASSAY KIT, MAG. SOLID PHAS
K872862 · Serono Diagnostics, Inc. · Sep 1987
BECKMAN EPSILON(TM) PROLACTIN TEST KIT
K864439 · Beckman Instruments, Inc. · Jan 1987
TANDEM-M IMMUNOENZYMETRIC ASSAY FOR PROLACTIN
K863860 · Hybritech, Inc. · Nov 1986
DELFIA (TM) HUMAN PROLACTIN
K861542 · Lkb Instruments, Inc. · Jun 1986
LEE-BEAD PROLACTIN (EIA)
K861945 · Leeco Diagnostics, Inc. · Jun 1986
ENCORE PROLACTIN REAGENT
K860221 · Hybritech, Inc. · Mar 1986